sumatriptan has been researched along with Cognition Disorders in 2 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Changes in migraine pain severity, clinical disability, and percent effectiveness following treatment with sumatriptan nasal spray, 20 mg, were significantly correlated with cognitive function measures across all subtests (P<." | 2.70 | Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study. ( Batenhorst, A; Bleiberg, J; Cady, R; Farmer, K; O'Quinn, S; Putnam, G; Reeves, D, 2001) |
| "The question whether symptom-free migraine patients show cognitive impairments compared to matched control subjects is addressed, and also whether migraine patients show transient cognitive impairments induced by an attack." | 1.30 | Interictal and postictal cognitive changes in migraine. ( de Geus, EJ; Linssen, WH; Mulder, EJ; Orlebeke, JF; Passchier, J, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mulder, EJ | 1 |
| Linssen, WH | 1 |
| Passchier, J | 1 |
| Orlebeke, JF | 1 |
| de Geus, EJ | 1 |
| Farmer, K | 1 |
| Cady, R | 1 |
| Bleiberg, J | 1 |
| Reeves, D | 1 |
| Putnam, G | 1 |
| O'Quinn, S | 1 |
| Batenhorst, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Evaluation of Treximet in the Treatment of Acute Migraine Headache: A Placebo-Controlled, Double-Blind, Crossover Study, Assessing Cognitive Function.[NCT00837044] | 30 participants (Anticipated) | Interventional | 2009-02-28 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sumatriptan and Cognition Disorders
| Article | Year |
|---|---|
Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study.
Topics: Acute Disease; Administration, Intranasal; Adult; Cognition; Cognition Disorders; Female; Humans; Me | 2001 |
1 other study available for sumatriptan and Cognition Disorders
| Article | Year |
|---|---|
Interictal and postictal cognitive changes in migraine.
Topics: Adult; Attention; Cognition Disorders; Female; Humans; Male; Migraine Disorders; Neurocognitive Diso | 1999 |